Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 16.97
Key Takeaways
Risk factor
Good trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
TINAVI Medical Technologies Co., Ltd. engages in the research and development, production, and clinical application of orthopedic robotic systems. It offers TiRobot, an orthopedic robotic system used in orthopedic surgeries for spine and trauma. The company was founded in 2010 and is based in Beijing, China.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers.
Data is available to registered users only
Buy
Sell